The cyclic AMP signaling pathway: Exploring targets for successful drug discovery (Review)
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
During development of disease, complex intracellular signaling pathways regulate an intricate series of events, including resistance to external toxins, the secretion of cytokines and the production of pathological phenomena. Adenosine 3',5'-cyclic monophosphate (cAMP) is a nucleotide that acts as a key second messenger in numerous signal transduction pathways. cAMP regulates various cellular functions, including cell growth and differentiation, gene transcription and protein expression. This review aimed to provide an understanding of the effects of the cAMP signaling pathway and the associated factors on disease occurrence and development by examining the information from a new perspective. These novel insights aimed to promote the development of novel therapeutic approaches and aid in the development of new drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since ABC transporters actively mediate phospholipid translocation (Musselman and Kühnlein, 2018; Yan et al., 2016), loss of iPLA-VIA function likely impairs phospholipid metabolism, affecting the intracellular distribution of other metabolites.”
From Decanoic acid extends lifespan and modulates metabolism in models of PLA2G6 -associated neurodegeneration (2025) · cites this paper as Yan et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emergent Properties of Networks of Biological Signaling Pathways
Bhalla, U. S., & Iyengar, R. (1999) · Science · doi:10.1126/science.283.5400.381 · Cited by 1,686 · cited 1×
“These two second messengers regulate a variety of cellular functions, including protein synthesis, protein phosphorylation, the regulation of enzymatic activity (110) and gene expression.”
Silva, A. J., Kogan, J. H., Frankland, P. W., & Kida, S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.127 · Cited by 1,462
Patterson, S. L., Abel, T., Deuel, T. A. S., Martin, K. C., Rose, J. C., & Kandel, E. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80140-3 · Cited by 1,233 · cited 1×
“…including the regulation of neurotransmitter synthesis (19), regulation of membrane protein activity, participation in ganglion synaptic transmission (20) and regulation of transcription factors in eukaryotic cells (21), cAMP may be involved in the prevention and treatment of various diseases.”
Guanylate cyclase and the ⋅NO/cGMP signaling pathway
Denninger, J. W., & Marletta, M. A. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00024-9 · Cited by 1,040
Parker, D., Ferreri, K., Nakajima, T., Lamorte, V. J., Evans, R., Koerber, S. C., Hoeger, C., & Montminy, M. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.2.694 · Cited by 408
Park, P.-H., Huang, H., McMullen, M. R., Bryan, K., & Nagy, L. E. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907631 · Cited by 53
Chang, S., Kim, D., Ryu, G. R., Ko, S., Jeong, I., Ahn, Y., Jo, Y., & Kim, M. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24425 · Cited by 44 · cited 1×
“Second messenger pathways are associated with numerous conditions and diseases, including inflammation (6,7), cancer (8,9), myocardial atrophy (2), asynodia (10) and depression (11).”
Cited by
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Vigano, S., Alatzoglou, D., Irving, M., Ménétrier-Caux, C., Caux, C., Romero, P., & Coukos, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00925 · Cited by 420
Mehta, M., Dhanjal, D. S., Paudel, K. R., Singh, B., Gupta, G., Rajeshkumar, S., Thangavelu, L., Tambuwala, M. M., Bakshi, H. A., Chellappan, D. K., et al. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00698-3 · Cited by 330
Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis
Yu, S., Meng, S., Xiang, M., & Ma, H. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101257 · Cited by 261
Gupta, A. K., Gupta, S., Mehan, S., Khan, Z., Das Gupta, G., & Narula, A. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05001-5 · Cited by 59
“…signaling pathways involves various proteins such as exchange protein activated by cAMP (EPAC), PKA, cyclic nucleotide-gated channels (CNG), and hyperpolarization-activated cyclic nucleotide-gated channels (HCN), Popeye domain-containing protein (POPDC), and cyclic nucleotide receptor (CRIS) [108].”
Wang, H., Wen, C., Chen, S., Wang, F., He, L., Li, W., Zhou, Q., Yu, W. K., Huang, L., Chen, J., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114014 · Cited by 32
Hasan, N., Zameer, S., Najmi, A. K., Parvez, S., & Akhtar, M. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00482-x · Cited by 17
“Cyclic nucleotides, such as cyclic adenosine monophosphate (cAMP), are universal secondary messengers that regulate brain signalling (Yan et al. 2016).”
RetractedZhang, B., Dunn, E., Williams, R. S. B., Snowden, S., & Augustin, H. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052184
Metadata
- Authors
- YAN, K., GAO, L.-N., CUI, Y.-L., ZHANG, Y., & ZHOU, X.
- Venue
- Molecular Medicine Reports
- Publisher
- Spandidos Publications
- Published
- 2016-03-18
- Volume
- 13
- Issue
- 5
- Pages
- 3715-3723
- ISSN
- 1791-2997 (ISSN-L)
- 1791-3004
- OpenAlex
- W2302387728
- Cited by
- 214
- References
- 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.